Creative Planning »

Neurogene shares owned by Creative Planning

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Creative Planning

Quarter filed Position value Share count Share price at filing
2024-12-31 $937 41 22.85

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Series Trust Portfolio S&p400 (SPMD)
Ishares Core Msci Emkt (IEMG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Apple (AAPL)
Spdr Series Trust Portfolio S&p500 (SPLG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for Creative Planning

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene